December 1, 2016 - By Hazel Jackson · 0 Comments
The stock of Dehaier Medical Systems Limited (NASDAQ:DHRM) registered an increase of 39.56% in short interest. DHRM’s total short interest was 12,700 shares in December as published by FINRA. Its up 39.56% from 9,100 shares, reported previously. With 26,700 shares average volume, it will take short sellers 1 days to cover their DHRM’s short positions. The short interest to Dehaier Medical Systems Limited’s float is 0.64%. The stock last traded at $1.59 per share. It is down 15.87% since April 28, 2016 and is downtrending. It has underperformed by 21.80% the S&P500.
Lianluo Smart Ltd, formerly Dehaier Medical Systems Limited, distributes and provides after-sale services for medical equipment in China through its subsidiary, Beijing Dehaier Medical Technology Co. The company has a market cap of $27.19 million. Limited , and its affiliate, Beijing Dehaier Technology Limited (BTL). It currently has negative earnings. The Company, through its subsidiaries and affiliate, distributes branded medical equipment, such as sleep apnea machines, ventilator air compressors, Color Dopller Imaging Machine and laryngoscope.
More notable recent Lianluo Smart Ltd (NASDAQ:LLIT) news were published by: Prnewswire.com which released: “Dehaier Changes Name to Lianluo Smart Limited, Announces Strategic Personnel …” on October 25, 2016, also Prnewswire.com with their article: “Dehaier Medical Changed its Name to Lianluo Smart” published on November 18, 2016, Sacbee.com published: “Weekly Summary Corporate dividends, name changes, new listings” on November 25, 2016. More interesting news about Lianluo Smart Ltd (NASDAQ:LLIT) were released by: Techcrunch.com and their article: “Razer Raises At A $1.5B Valuation, With $75M From China’s Digital Grid For …” published on February 23, 2016 as well as Pehub.com‘s news article titled: “Lian Luo leads $24 mln Series B funding in Avegant” with publication date: August 24, 2015.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Hazel Jackson